Funding an annual Amanda Riley Research Grant for Rhabdomyosarcoma

• 
  
  • We funded our first annual $25,000 research grant. This grant went to fund researcher Madeline Hayes out of Boston. Rhabdomyosarcoma has a 70% recurrence rate due to self-renewing tumor cells which causes relapse. At this time there are no treatments for children if they indeed relapse. Her research is geared toward eliminating these cells and the patients would remain relapse free.